Effect of Individualized Nursing Care on Diabetes Self-Management
Condition(s) studied
Investigational drug(s) / intervention(s)
Individualized Nursing Care: Participants in this group receive structured, personalized nursing care sessions, including targeted education, individual goal-setting, self-monitoring guidance, and ongoing follow-up to enhance diabetes self-management.
Study summary
This randomized controlled trial aims to evaluate the effects of individualized nursing care interventions on self-efficacy, empowerment, and self-management behaviors in individuals diagnosed with diabetes. Diabetes requires lifelong management, and standard care approaches often fall short of meeting individual psychosocial and clinical needs. By implementing structured, patient-centered nursing care protocols, this study assesses how personalized education, follow-up, and support mechanisms influence patients' capacity to manage their condition, improve glycemic control, and enhance their overall quality of life.
Eligibility
Primary outcome measure(s)
- Adult Diabetes Knowledge Score — Baseline and 3 months
Change in adult diabetes knowledge score as measured by the Adult Diabetes Knowledge Scale (ADKS) from baseline to 3 months. (Total score ranging from 0 to 28 points). - Diabetes Self-Management Behaviors Score — Baseline and 3 months
Change in diabetes self-management score as measured by the Diabetes Self-Management Questionnaire (DSMQ) from baseline to 3 months. (Total and subscale points). - Diabetes Empowerment and Psychosocial Self-Efficacy Score — Baseline and 3 months
Change in diabetes empowerment score as measured by the Diabetes Empowerment Scale (DES) from baseline to 3 months. (Likert scale points ranging from 0 to 5).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Yalova Training and Research Hospital | Yalova | Turkey (Türkiye) |
More University of Yalova trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07808255 on ClinicalTrials.gov ↗ ← All trials in Turkey